Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease [Phase 3]
A Phase 3 trial compares radiotherapy after chemotherapy versus no radiotherapy in patients with Stage III/IV Hodgkin lymphoma to determine …
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Haplo Peripheral Blood Sct In GVHD Prevention [Phase 1]
Phase 1 trial update reporting the completion of a haploidentical peripheral blood stem cell transplantation approach for the prevention of …
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep [Phase 2]
Phase 2 clinical trial evaluating non-myeloablative preparative regimens followed by umbilical cord blood transplantation for various hemato…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Avelumab With Valproic Acid in Virus-associated Cancer [Phase 2]
Phase 2 trial evaluating the PD-L1 inhibitor avelumab in combination with valproic acid for virus-associated cancers has completed; the upda…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases [Phase 2]
A Phase 2 clinical trial is testing alpha/beta T cell and CD19+ B cell depletion in allogeneic stem cell transplantation for malignant disea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Palifermin (Kepivance) in patients undergoing unrelated donor allogeneic hematopoietic cell transplant…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation [Phase 2]
Phase 2 trial comparing three GVHD prophylaxis regimens in nonmyeloablative or reduced-intensity conditioning unrelated donor transplantatio…
-
CLINICAL_TRIALS trial_result · 2025-05-26Clinical Trial Update: Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating direct tumor microinjection and FDG-PET to test drug sensitivity in patients with relapsed or refractory n…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Administration of T Lymphocytes for Prevention of Relapse of Lymphomas [Phase 1]
Phase 1 clinical trial update evaluating administration of T lymphocytes to prevent relapse in Hodgkin lymphoma and other lymphomas; results…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
This completed clinical trial (NCT05053100) investigates the risk of blood clots and bleeding in patients with hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation [Phase 2]
Phase 2 trial evaluating tocilizumab to prevent graft-versus-host disease after cord blood transplantation has been completed.
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation. [Phase 4]
A Phase 4 pediatric Hodgkin lymphoma trial is assessing lower cumulative doses of chemotherapy with reduced radiation and is currently recru…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation [Phase 1]
Phase 1 study evaluating itacitinib for prophylaxis of graft-versus-host disease and cytokine release syndrome after T-cell replete haploide…
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors [Phase 2]
A Phase 2 trial evaluating α/β+-T lymphocyte-depleted donor grafts from HLA-mismatched donors in multiple hematologic malignancies was termi…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL [Phase 2]
A Phase 2 trial evaluating ipilimumab with or without nivolumab in relapsed/refractory Hodgkin lymphoma has posted results.
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Phase 2]
This Phase 2 trial investigates reduced-intensity chemotherapy and radiation therapy before donor stem cell transplantation for various hema…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma [Phase 1]
A Phase 1 study evaluating radiolabeled monoclonal antibody therapy in combination with chemotherapy before stem cell transplantation for ad…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating SL-279252, a PD-1-Fc-OX40L fusion protein, in adults with advanced solid tumors or lymphomas has been completed wit…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies [Phase 2]
Phase 2 trial evaluating reduced-intensity conditioning with fludarabine and melphalan plus total body irradiation for haploidentical stem c…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial update reporting results from a Phase 1/2 study of a conditioning regimen using gemcitabine hydrochloride, clofarabine, and b…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) [Phase 1]
Phase 1 trial evaluating LMP-, BARF1-, and EBNA1-specific cytotoxic T cells for EBV-positive lymphomas; Hodgkin and Non-Hodgkin lymphoma inc…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment [Phase 2]
Phase 2 study examining nivolumab plus brentuximab vedotin in patients aged 5-30 with relapsed or refractory classical Hodgkin lymphoma; the…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68) [Phase 2]
A Phase 2 study of pembrolizumab (MK-3475) in relapsed or refractory classical Hodgkin lymphoma and relapsed/refractory primary mediastinal …
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: The Efficacy of Salvage BGD With autoSCT Consolidation in Advanced Classical HL Patients Not Responding to ABVD [Phase 2]
Phase 2 study evaluating salvage BGD chemotherapy with autologous stem cell transplant consolidation in advanced classical Hodgkin lymphoma …
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluated a four-drug combination (doxorubicin, pembrolizumab, vinblastine, dacarbazine) for classical Hodgkin lymphoma. T…